| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥62.74B | ¥57.99B | +8.2% |
| Cost of Sales | ¥40.88B | ¥38.62B | +5.8% |
| Gross Profit | ¥21.87B | ¥19.37B | +12.9% |
| SG&A Expenses | ¥18.85B | ¥16.55B | +13.9% |
| Operating Income | ¥3.02B | ¥2.81B | +7.2% |
| Non-operating Income | ¥316M | ¥220M | +43.6% |
| Non-operating Expenses | ¥424M | ¥231M | +83.5% |
| Equity Method Investment Income | ¥40M | ¥17M | +135.3% |
| Ordinary Income | ¥2.91B | ¥2.80B | +3.8% |
| Profit Before Tax | ¥2.86B | ¥-1.53B | +286.8% |
| Income Tax Expense | ¥685M | ¥1.00B | -31.8% |
| Net Income | ¥2.18B | ¥-2.54B | +185.9% |
| Net Income Attributable to Owners | ¥2.19B | ¥-2.52B | +186.6% |
| Total Comprehensive Income | ¥2.61B | ¥-2.60B | +200.5% |
| Depreciation & Amortization | ¥2.43B | ¥2.31B | +5.2% |
| Interest Expense | ¥169M | ¥75M | +125.3% |
| Earnings per Unit (EPU) | ¥54.23 | ¥-63.18 | +185.8% |
| Distribution per Unit (DPU) | ¥18.00 | ¥9.00 | +100.0% |
| Total Dividend Paid | ¥736M | ¥736M | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥47.34B | ¥39.14B | +¥8.20B |
| Cash and Deposits | ¥10.19B | ¥6.10B | +¥4.09B |
| Accounts Receivable | ¥18.86B | ¥16.70B | +¥2.15B |
| Inventories | ¥8.04B | ¥6.14B | +¥1.91B |
| Non-current Assets | ¥28.10B | ¥25.45B | +¥2.65B |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥3.39B | ¥4.85B | ¥-1.46B |
| Investing Cash Flow | ¥-5.56B | ¥-2.94B | ¥-2.62B |
| Financing Cash Flow | ¥6.20B | ¥-2.65B | +¥8.85B |
| Free Cash Flow | ¥-2.16B | - | - |
| Item | Value |
|---|---|
| Operating Margin | 4.8% |
| ROA (Ordinary Income) | 4.2% |
| Payout Ratio | 33.2% |
| Dividend on Equity (DOE) | 2.7% |
| Book Value Per Share | ¥671.41 |
| Net Profit Margin | 3.5% |
| Gross Profit Margin | 34.8% |
| Current Ratio | 124.3% |
| Quick Ratio | 103.2% |
| Debt-to-Equity Ratio |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +8.2% |
| Operating Income YoY Change | +7.2% |
| Ordinary Income YoY Change | +3.8% |
| Net Income Attributable to Owners YoY Change | -10.7% |
| Item | Value |
|---|---|
| Units Outstanding (incl. Treasury) | 41.10M shares |
| Treasury Units | 736K shares |
| Average Units Outstanding | 40.33M shares |
| NAV per Unit | ¥678.79 |
| EBITDA | ¥5.44B |
| Item | Amount |
|---|---|
| Q2 Distribution | ¥9.00 |
| Year-End Distribution | ¥9.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| FineChemicals | ¥23.26B | ¥909M |
| HealthAndBeautyCareFood | ¥18.27B | ¥700M |
| IndustrialChemicals | ¥9.74B | ¥733M |
| Medical | ¥12.75B | ¥1.12B |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥68.00B |
| Operating Income Forecast | ¥3.40B |
| Ordinary Income Forecast | ¥3.30B |
| Net Income Attributable to Owners Forecast | ¥2.35B |
| Earnings per Unit Forecast (EPU) | ¥58.22 |
| Distribution per Unit Forecast (DPU) | ¥9.00 |
| Property, Plant & Equipment | ¥13.29B | ¥11.92B | +¥1.37B |
| Intangible Assets | ¥7.64B | ¥6.89B | +¥745M |
| Goodwill | ¥4.75B | ¥3.75B | +¥1.00B |
| Investment Securities | ¥4.29B | ¥4.14B | +¥154M |
| Total Assets | ¥75.44B | ¥64.59B | +¥10.85B |
| Current Liabilities | ¥38.07B | ¥31.90B | +¥6.17B |
| Accounts Payable | ¥9.55B | ¥9.27B | +¥279M |
| Short-term Loans | ¥16.20B | ¥11.39B | +¥4.80B |
| Non-current Liabilities | ¥9.97B | ¥7.39B | +¥2.58B |
| Long-term Loans | ¥6.25B | ¥3.44B | +¥2.81B |
| Total Liabilities | ¥48.04B | ¥39.29B | +¥8.75B |
| Total Equity | ¥27.40B | ¥25.30B | +¥2.10B |
| Capital Stock | ¥4.63B | ¥4.61B | +¥24M |
| Capital Surplus | ¥6.34B | ¥6.32B | +¥24M |
| Retained Earnings | ¥13.68B | ¥12.23B | +¥1.45B |
| Treasury Stock | ¥-255M | ¥-255M | ¥0 |
| Owners' Equity | ¥27.10B | ¥25.16B | +¥1.93B |
| Working Capital | ¥9.27B | - | - |
| 1.75x |
| Interest Coverage Ratio | 17.85x |
| EBITDA Margin | 8.7% |
| Effective Tax Rate | 23.9% |